Can we avoid surgery in elderly patients with renal masses by using the Charlson comorbidity index?

BJU International

Volumn 103, Issue 11, 2009, Pages 1492-1495

  O'Connor, Kevin M ^a,b   Davis, Niall ^a   Lennon, Gerry M ^a   Quinlan, David M ^a   Mulvin, David W ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

Charlson comorbidity index; Renal tumour; Surveillance

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER GROWTH; CLINICAL ARTICLE; COMORBIDITY; DISEASE SURVEILLANCE; FEMALE; FOLLOW UP; HEMATURIA; HUMAN; HUMAN TISSUE; KIDNEY CANCER; KIDNEY TUMOR; LUNG METASTASIS; LYMPHADENOPATHY; MALE; MEDICAL RECORD REVIEW; NEPHRECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR BIOPSY; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEPHRECTOMY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 65549116903     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08275.x     Document Type: Article

References (26)

1. Gibbons RP, Monte JE, Correa RJ Mason JT. Manifestations of renal cell carcinoma. Urology 1976 8 : 201 6
2. Chow WH, Devessa SS, Warren JL et al. Rising incidence of renal call cancer in the United States. JAMA 1999 281 : 1628 31 (Pubitemid 29211773)
3. Hock LM, Lynch J, Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol 2002 167 : 57 60 (Pubitemid 34024497)
4. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 1998 51 : 203 5 (Pubitemid 28093168)
5. Liguori G, Trombetta C, Pomara G et al. Major invasive surgery for urologic cancer in octogenarians with comorbid medical conditions. Eur Urol 2007 51 : 1600 5 (Pubitemid 46634729)
6. Patard JJ, Shvarts O, Lam JS et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 2004 171 : 2181 5 (Pubitemid 38625430)
7. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003 170 : 2217 20 (Pubitemid 37413960)
8. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. Natl Cancer Inst 2006 98 : 1331 4 (Pubitemid 44530728)
9. Lam JS, Shvarts O, Pantuck AJ. Changing concepts in the surgical management of renal cell carcinoma. Eur Urol 2004 45 : 692 705 (Pubitemid 38638388)
10. Inouye SK, Peruzzi PN, Robison JT, Hughes JS, Horwitz RI, Concato J. Importance of functional measures in predicting mortality among older hospitalized patients. JAMA 1998 279 : 1187 93 (Pubitemid 28193429)
11. Fitzpatrick JM. Management of localized prostate cancer in senior adults: the crucial role of comorbidity. BJU Int 2008 101 (Suppl. 2 16 22
12. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001 285 : 2750 6 (Pubitemid 32525372)
13. Repetto L, Comandini D. Cancer in the elderly: assessing patients for fitness. Crit Rev Oncol Hematol 2000 35 : 155 60
14. Rochon PA, Katz JN, Morrow LA et al. Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability. A prospective comparison of three comorbidity indices. Med Care 1996 34 : 1093 101 (Pubitemid 126433208)
15. D'Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med 1993 32 : 382 7 (Pubitemid 24001924)
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987 40 : 373 83 (Pubitemid 17055592)
17. Santos Arrontes D, Fernández Aceñero MJ, García González JI, Martín Muñoz M, Paniagua Andrés P. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index. J Urol 2008 179 : 857 61
18. Gettman M, Boelter CW, Cheville JC, Zincke H, Bryant SC, Blute ML. Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension. J Urol 2003 169 : 1282 (Pubitemid 36323767)
19. Crispen PL, Uzzo RG. The natural history of untreated renal masses. BJU Int 2007 99 : 1203 7 (Pubitemid 46624160)
20. Kassouf W, Aprikian AG, Laplante M, Tanguay S. Natural history of renal masses followed expectantly. J Urol 2004 171 : 111 3 (Pubitemid 37549102)
21. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006 175 : 425 31 (Pubitemid 43067318)
22. Kunkle DA, Crispen PL, Chen DY, Greenberg RE, Uzzo RG. Enhancing renal masses with zero net growth during active surveillance. J Urol 2007 177 : 849 53 (Pubitemid 46216338)
23. Klatte T, Patard JJ, de Martino M et al. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. J Urol 2008 179 : 1719 26
24. Barocas DA, De Mathew SI, Pizzo JJ et al. Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen. BJU Int 2007 99 : 290 5 (Pubitemid 46103106)
25. Volpe A, Kachura JR, Geddie WR et al. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol 2007 178 : 379 86 (Pubitemid 47030509)
26. Matter K, Basiuk J, Finelli A et al. Active surveillance of small renal masses: a prospective multi-centre Canadian trial. Eur J Urol 2008 7 (Suppl. 3 309